Lineage Cell Therapeutics (LCTX) FCF Margin Growth (1y) (2011 - 2026)
Lineage Cell Therapeutics (LCTX) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | -13,972.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,972.00 |
| Dec 31, 2025 | 15,924.00 |
| Sep 30, 2025 | 5,520.00 |
| Jun 30, 2025 | 17,033.00 |
| Mar 31, 2025 | 7,136.00 |
| Dec 31, 2024 | 5,204.00 |
| Sep 30, 2024 | 26,431.00 |
| Jun 30, 2024 | -16,778.00 |
| Mar 31, 2024 | 7,446.00 |
| Dec 31, 2023 | 12,001.00 |
| Sep 30, 2023 | -22,308.00 |
| Jun 30, 2023 | -4,614.00 |
| Mar 31, 2023 | -89,495.00 |
| Dec 31, 2022 | -40,060.00 |
| Sep 30, 2022 | 2,362.00 |
| Jun 30, 2022 | 92,577.00 |
| Mar 31, 2022 | 231,891.00 |
| Dec 31, 2021 | 158,374.00 |
| Sep 30, 2021 | 63,712.00 |
| Jun 30, 2021 | 1,673.00 |